As companies race to develop the first fully-automated insulin delivery system, a group of tech-savvy patients are hacking their own artificial pancreas systems. And industry is just starting to take notice of this highly motivated grassroots movement. “They want more choice. They want more freedom. And, essentially, they want it now,” JDRF research director Dan […]
Wall Street Beat
Edwards Lifesciences slides on Q3 sales, earnings misses
Edwards Lifesciences (NYSE:EW) missed the mark with its third-quarter sales and earnings, despite posting healthy, double-digit increases to both the top and bottom line, sending share prices down today in after-market trading. The Irvine, Calif.-based implantable heart valve maker posted profits of $170.1 million, or 79¢ per share, on sales of $821.5 million for the three […]
J&J’s LifeScan touts studies of OneTouch blood glucose monitoring system
Two recently-published studies of LifeScan‘s OneTouch Verio Flex blood glucose monitoring system showed that the technology is accurate, reliable and linked with improvements in glycemic control, the Johnson & Johnson (NYSE:JNJ) business touted today. The release comes just days after the healthcare giant revealed that it plans to shut down its Animas insulin pump business and review its LifeScan division. […]
Catalent reorganizes after closing Pharmica purchase
Cook Group said today that it completed the sale of Cook Pharmica to Catalent (NYSE:CTLT). Catalent announced last month that it planned to dish out $950 million to buy the biologics contract manufacturer. The newly-acquired company will be called Catalent Bloomington, according to Cook Group. Get the full story at our sister site, Drug Delivery Business News.
Income, sales rise for 3M Health Care’s during Q3
Sales and operating profits for the healthcare business at 3M Cos. (NYSE:MMM) rose during the third quarter, helping the industrial conglomerate top the consensus sales and earnings forecasts and sending share prices up today on Wall Street. 3M Health Care’s operating profits rose 9.3% to $471 million for the three months ended Sept. 30, compared […]
FDA clears Acutus Medical’s AcQMap cardiac mapping tech
Acutus Medical said today that it won 510(k) clearance from the FDA for its AcQMap high-resolution imaging & mapping system and the 3D mapping catheter that goes by the same name. Carlsbad, Calif.-based Acutus said it plans to have the system on the U.S. market early next year. It’s designed to detect and display standard voltage-based […]
NeuroPace raises $74m for anti-epilepsy implant
NeuroPace said today that it raised a $74 million funding round, saying it plans to use the infusion to speed the commercialization of its implantable neurostimulation device for treating epilepsy. Mountain View, Calif.-based NeuroPace said the round was led by the KCK Group and OrbiMed Advisors. NeuroPace’s RNS system monitors electrical activity in the brain, delivering stimulative therapy […]
Ypsomed to supply Bigfoot with insulin infusion sets for pivotal trial
Ypsomed plans to supply Bigfoot Biomedical with a modified version of its Orbit infusion set for the pivotal trial of Bigfoot’s automated insulin delivery system, the companies said today. Ypsomed’s Orbit infusion sets can be rotated 360°, giving users the freedom to move around, and are fitted using a heat-activated patch. The infusion sets are available with steel or […]
Exactech to go private in TPG Capital acquisition
Exactech (NSDQ:EXAC) said it inked a definitive merger agreement to be acquired by TPG Capital in a move that will take the company private. Under the deal, TPG Capital will pay approximately $42 per share to acquire all outstanding shares of Gainesville, Fla.-based Exactech, excluding a select number of management stockholders who agreed to exchange a portion […]
Cerveau inks licensing deal with AbbVie for tau imaging agent
Cerveau Technologies has inked a deal to license and supply AbbVie (NYSE:ABBV) with its [F-18]MK-6240 investigational tau imaging agent, the company said today. After the FDA cleared the investigational new drug application for Cerveau’s imaging agent in June, the company said it planned to work with pharmaceutical partners to evaluate the product’s use in positron emission tomography scans to assess […]
United Therapeutics wins FDA nod for third-gen Tyvaso TD-300/A nebulizer
United Therapeutics (NSDQ:UTHR) said today that its third-generation inhalation device designed for use with its Tyvaso treprostinil inhalation solution won FDA approval. Tyvaso first won FDA approval in 2009 as a treatment for pulmonary arterial hypertension, the company said, with an ultrasonic nebulizer. United Therapeutics touted its drug-device combo as the most-prescribed inhalation therapy for PAD […]